NIH Emergency Competitive Revision Guide
Updated 7 official sources
Quick Answer: PA-24-201 emergency competitive revision eligibility turns on 7 checks: active NIH parent award, applicable Emergency NOSI, declared disaster or public-health-emergency basis, IC routing, scope fit, clinical-trial boundary, and rapid budget justification.
Full answer and how we checked it
PA-24-201 emergency competitive revision eligibility turns on 7 checks: active NIH parent award, applicable Emergency NOSI, declared disaster or public-health-emergency basis, IC routing, scope fit, clinical-trial boundary, and rapid budget justification.
Who this is for: NIH award recipients, research administrators, disaster-response research teams, public-health emergency teams, clinical investigators, and sponsored-research offices deciding whether PA-24-201 is the right emergency supplement route.
Data note: This guide uses the official NIH PA-24-201 NOFO, Grants.gov listing 353623, NIH clinical-trial policy pages, and Grantsights award-data signals checked on May 19, 2026. On October 9, 2026, Grantsights rechecked the NOFO, NIH's list of NOSIs tied to PA-24-201 (opens in a new tab), and NIH RePORTER records for awards made under it.
In this guide
- 7 PA-24-201 Eligibility Stop Checks
- 5 Source Facts Applicants Should Know
- October 2026 Status: No Active Emergency NOSI
- What Past Emergency Revisions Funded
- What NIH Doesn't Tell You
- 6 Evidence Assets That Make This Proposal Stronger
- 5 Route Choices Before Drafting
- 6 Bad-Fit Signals
- 21-Day Emergency Revision Readiness Plan
- 6 Final Research Checks Before Submission
- 4 Public Decision Questions
- 3 Last-Mile Checks For Emergency Teams
- Sources
Quick Facts
- Agency
- HHS
- Deadline
- Apr 18, 2027
- Status
- Open
Assistance Listing 93.142: all awards
Source: USASpending.gov FY2024These figures cover all National Institutes of Health awards under Assistance Listing 93.142, of every award type. They are not figures for the award this guide describes, and one award of that kind can be far smaller.
- Total Awards (FY2024, whole listing)
- 34
- Avg Award (whole listing)
- $16,950,857
- Median Award (whole listing)
- $12,427,855
- Total Funding (FY2024, whole listing)
- $35.6M
- YoY Funding Trend
- -5.3%
Data last verified: May 19, 2026
According to NIH PA-24-201 (opens in a new tab), NIH may accept emergency competitive revision applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary of HHS, or another local, regional, or national disaster. NIH marks the NOFO as Clinical Trial Optional.
This route is not a general supplement. NIH says only applications submitted in response to an Emergency Notice of Special Interest published by an institute or center may apply. That means the first question is not "Is the work urgent?" It is "Do we have an active parent award and a matching Emergency NOSI?"
Use this guide with the live Grantsights program record. Then compare NIH grants complete guide, what is a NOFO, NINDS U01 renewal guide, NIH PET and SPECT ligands guide, and the Grantsights grant database.
7 PA-24-201 Eligibility Stop Checks
| Stop check | Strong PA-24-201 signal | Red flag |
|---|---|---|
| Parent award | Active NIH grant or cooperative agreement exists | No active eligible parent |
| Emergency NOSI | Matching IC Emergency NOSI exists | No NOSI route |
| Emergency basis | Disaster or public health emergency connection is clear | Urgency is only internal |
| IC routing | Awarding IC matches parent NoA and NOSI | Wrong IC or unclear routing |
| Scope | Revision extends parent work for emergency need | New standalone project |
| Trial boundary | Clinical trial status is explicit | Human-subjects plan is vague |
| Budget | Budget matches emergency work | Budget rebuilds parent award |
Teams sometimes treat this as a fast supplement when it is actually a rule-heavy emergency route. Missing the NOSI condition is the fastest way to lose time.
5 Source Facts Applicants Should Know
According to NIH, PA-24-201 applications are routed directly to the NIH awarding component listed on the Notice of Award of the most recent parent award.
According to NIH, only applications submitted in response to an Emergency NOSI published by an IC are allowed. NIH also says individuals must hold an active grant or cooperative agreement award.
According to NIH RePORTER (opens in a new tab), PA-24-201 has funded 1 award so far: $1,607,741 from NIDA, noticed September 18, 2024. The Grants.gov record names six assistance listings, so listing-wide spending totals don't measure this route.
| Fact | Source-backed read |
|---|---|
| Funding number | PA-24-201 |
| Route type | Emergency competitive revision |
| Clinical trial status | Clinical Trial Optional |
| Parent award | Active NIH grant or cooperative agreement required |
| Live listing | Grants.gov listing 353623 |
October 2026 Status: No Active Emergency NOSI
The NOFO is live, but the route is dormant. According to the PA-24-201 NOFO (opens in a new tab), the posted date was April 18, 2024 and the expiration date is April 19, 2027. It reissued PA-20-135 and was updated March 31, 2025 to align with agency priorities. As of October 9, 2026, NIH's NOSI list for PA-24-201 (opens in a new tab) shows only one NOSI, and it's expired: NOT-DA-24-013 from NIDA, released May 20, 2024 and expired July 13, 2024, which offered emergency competitive revisions for coordinating center infrastructure on opioid overdose and HIV risk in justice settings.
That means no one can apply today. An application needs an Emergency NOSI that refers to this NOFO, and due dates, start dates, and extra review considerations all come from that NOSI. Watch the NOSI list and the NIH Guide (opens in a new tab) after a declared disaster or public health emergency.
| NOFO element | What PA-24-201 says |
|---|---|
| Participating ICs | NCATS, NIAID, NIAMS, NIDA, NIEHS, NIMHD |
| Latest IC added | NCATS, March 24, 2026 (NOT-TR-26-008 (opens in a new tab)) |
| Activity codes | Set by each Emergency NOSI |
| Budget | Not limited; must reflect actual needs |
| Project period | Parent award must be active at submission |
| Page limits | Those of the parent award's activity code, unless the NOSI says otherwise |
| Number of applications | More than one allowed if each is sufficiently distinct |
| Review | Internal review panel convened by the awarding IC, using the NOSI's added considerations |
| Expiration | April 19, 2027 |
If your parent award sits at an IC that isn't on that list, this NOFO can't carry your request even if an emergency hits your study site.
How NIH reviews an emergency revision
Review isn't the standard study-section process. The NOFO says an internal panel convened by the awarding IC's staff evaluates scientific and technical merit and gives an overall impact score. Under the Emergency Applications criterion, NIH staff weigh how well the application responds to the Emergency NOSI. Reviewers also judge responsiveness to "the immediate need" of the specific public health crisis, though that factor isn't scored separately. Human subjects protections, inclusion across sex, race, ethnicity, and age, vertebrate animals, and biohazards are reviewed as they are for other NIH applications. NIH staff also check that the budget and period of support are justified.
Two paperwork rules catch teams. First, the Data Management and Sharing Plan follows the parent award: if the revision changes the parent's approved data-sharing approach, an updated DMS Plan goes to the IC before award. Second, the human subjects form needs at least one study record (or a Delayed Onset record) whenever human subjects are involved.
What Past Emergency Revisions Funded
Grantsights checked NIH RePORTER on October 9, 2026. Only 1 award lists PA-24-201. For example, RTI received $1,607,741 from NIDA as 3U24DA057611-03S2 (opens in a new tab) for the EngageData Hub coordinating center, noticed September 18, 2024. That matches the single expired NIDA NOSI, and it was a revision to an existing U24, not a new project.
The predecessor, PA-20-135, shows a very different pattern. RePORTER lists 312 records under it from FY2020 through FY2023 (167 in FY2020, 111 in FY2021, 33 in FY2022, 1 in FY2023), and nearly half name COVID-19, SARS-CoV-2, or coronavirus in the title. Grantsights analysis of those 312 records shows emergency revisions follow declared emergencies, not the calendar. Examples include NIMHD's supplement to Ponce School of Medicine for post-Hurricane Maria cancer care (3R21MD013674-02S3, $509,208) and NIEHS supplements for community COVID-19 testing at the University of Chicago (3R01ES028615-06S1, $1,609,765). Sizes ranged from under $100,000 to more than $20 million for a COVID-19 vaccine trial supplement.
What NIH Doesn't Tell You
Within 21 days, answer 4 practical questions. First, an emergency supplement is not just "we need money quickly." The route depends on the emergency authority, active award, and matching NOSI.
Second, the scope has to attach to the parent award. A parent-award team adding disaster-related data collection under a relevant Emergency NOSI could fit. A team proposing a separate new project because it's urgent needs another route. The NOFO also bars using the revision to add, delete, or change PDs/PIs on the parent award.
Third, the budget should look like a revision, not a new grant. Reviewers need to see why the emergency work cannot wait and why each cost is tied to the parent award.
Fourth, foreign organizations can apply here. Unlike many NIH NOFOs, PA-24-201 lists non-U.S. entities and non-U.S. components of U.S. organizations as eligible, as long as they administer an eligible parent award.
6 Evidence Assets That Make This Proposal Stronger
Within 21 days, build 6 evidence assets. Asset 1 is the parent-award memo. List grant number, PI, active dates, parent aims, awarding IC, and NoA details.
Asset 2 is the Emergency NOSI memo. Identify the exact NOSI, expiration, eligible ICs, topics, and any special instructions.
Asset 3 is the emergency-basis memo. Connect the proposed work to the declared disaster, public health emergency, or other allowed emergency context.
Asset 4 is the scope map. Tie each revision activity to the parent award and emergency need.
Asset 5 is the budget-to-emergency crosswalk. Tie personnel, supplies, data, travel, subawards, and participant costs to urgent work.
Asset 6 is the route memo. Compare PA-24-201 with administrative supplement, competitive revision, new R01, R21, U01, contract, or non-NIH emergency funding.
5 Route Choices Before Drafting
Within 21 days, compare 5 routes.
| Route | Better first read when... | Why |
|---|---|---|
| PA-24-201 | Active parent award and Emergency NOSI fit | Emergency route fits |
| Administrative supplement | Need is narrow and noncompetitive | Lower burden may fit |
| Standard revision | Urgency lacks emergency authority | Non-emergency route may fit |
| New award | Work is standalone | New project route may fit |
| Non-NIH emergency funds | Agency or response context differs | Better funder may fit |
Warning: if there is no matching Emergency NOSI, don't start with PA-24-201.
6 Bad-Fit Signals
First, no active NIH parent award exists. Second, no Emergency NOSI fits. Third, the work is not tied to a disaster or public health emergency.
Fourth, the project is standalone. Fifth, clinical-trial status is unclear. Sixth, budget scope looks like a new award.
These signals are route blockers.
21-Day Emergency Revision Readiness Plan
Days 1 through 3 should confirm active parent award, awarding IC, Emergency NOSI, and emergency basis. Days 4 through 7 should write parent-award, NOSI, and emergency-basis memos.
Days 8 through 12 should build scope and budget crosswalks. Days 13 through 16 should check clinical-trial status, human-subjects forms, IC instructions, and institutional approvals. Days 17 through 21 should compare alternate routes and finalize submission timing.
6 Final Research Checks Before Submission
Within 21 days, finish 6 final checks. Check 1 is the NIH PA-24-201 NOFO (opens in a new tab). Check 2 is the applicable Emergency NOSI. Check 3 is active parent award status. Check 4 is emergency basis. Check 5 is clinical-trial status. Check 6 is budget-to-scope fit.
You're ready when the team can state the parent award, Emergency NOSI, emergency basis, revision scope, clinical-trial status, and budget reason in 6 direct sentences.
4 Public Decision Questions
Within 21 days, ask 4 public decision questions. Question 1: "Do you have an active NIH parent award?" Question 2: "Which Emergency NOSI applies?" Question 3: "How does the work connect to the emergency basis?" Question 4: "Does the scope stay tied to the parent award?"
If question 2 fails, the route isn't viable, no matter how strong the science is.
3 Last-Mile Checks For Emergency Teams
Within 21 days, run 3 last-mile checks. Check 1 is parent-award proof. Check 2 is Emergency NOSI proof. Check 3 is emergency-scope proof.
If those checks are weak, a program officer conversation should happen before writing. A final note for applicants: write the PA-24-201 fit sentence before the abstract. In 2 sentences, state the parent award, Emergency NOSI, emergency basis, revision work, and reason this route is correct.
Sources
Largest awards active in FY2024
One row per recipient, its largest award | 34 Assistance Listing records | Avg: $17.0M
CPWR: the Center for Construction Research and Training
MD
The University of Iowa
IA
Use the visible recipient rows as free source context
This program has no reviewed paid report today.
No reviewed paid report is currently offered for this program. The visible source rows remain free.
Frequently Asked Questions
What does PA-24-201 support?
It supports emergency competitive revision applications to existing NIH awards when funds may be available based on a declared disaster or public health emergency.
Is an active parent award required?
Yes. NIH says individuals must hold an active grant or cooperative agreement award.
Is an Emergency NOSI required?
Yes. NIH says only applications submitted in response to an Emergency NOSI published by an IC are allowed. As of October 9, 2026, NIH lists no active NOSI for PA-24-201.
Are clinical trials allowed?
Yes. NIH marks the NOFO as Clinical Trial Optional.
Who should skip this route?
Skip it when there is no active eligible parent award, no applicable Emergency NOSI, or the request is not tied to the emergency basis.
Last updated October 13, 2026. Corrected October 13, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
Complete Guide
NIH Grants 2026: R01, K Awards, R21, R35, SBIR
Compare NIH R01, K awards, R21, R03, R35, SBIR/STTR, success rates, deadlines, and program pages before choosing a route.
NIH Clinical Center U01 Eligibility Guide
NIH Clinical Center U01 guide: 8 checks for PAR-26-116, intramural collaboration, Clinical Center use, $500K direct-cost cap, and LOS prep.
NIH K24 Midcareer Investigator Award Guide
NIH K24 midcareer investigator award eligibility guide for PA-24-188, 25% to 50% effort, mentoring proof, trial limits, and route choice.
Latin America health disparities R01 eligibility Guide
NIMHD ended PAR-25-342 early on June 3, 2026. What the Latin America R01 covered, 8 fit checks, and where to look for current NIMHD funding.
NIH NextTech R18 Guide 2026: Eligibility
NIH NextTech R18 guide for 2026: eligibility, $6M program funding, BRAIN and HEAL fit, first-in-human readiness, and trial limits.
PA-25-304: NIH Parent R21 (Clinical Trial Not Allowed)
PA-25-304 is NIH's parent R21 with no clinical trial: $275,000 over 2 years, 21 institutes. Next due Nov 16, 2026 and Feb 16, 2027; expires Jan 8, 2028.